The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients. Luukkonen PK, Qadri S, Lehtimaki TE, Juuti A, et al. J Clin Endocrinol Metab 2021;106:e300-e315.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Luukkonen PK, Qadri S, Lehtimaki TE, Juuti A, et al. The PNPLA3-I148M Variant Confers an Antiatherogenic Lipid Profile in Insulin-resistant Patients. J Clin Endocrinol Metab 2021;106:e300-e315.
PMID: 33064150